Bruker (BRKR) Income from Non-Controlling Interests (2010 - 2026)
Bruker's (BRKR) quarterly Income from Non-Controlling Interests came in at $1.3 million in Q1 2026, up 316.67% YoY from $312000.0 in Q1 2025, and down 59.38% on a QoQ basis from $3.2 million in Q4 2025.
Bruker (BRKR) Income from Non-Controlling Interests (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Income from Non-Controlling Interests data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Income from Non-Controlling Interests rose 316.67% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 320.0% YoY) and the FY2025 annual result came in at $300000.0, down 57.14% from the prior year.
- Income from Non-Controlling Interests fell to $1.3 million in Q1 2026, from $3.2 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $3.2 million in Q4 2022 to a low of -$3.4 million in Q2 2025.
- A 5-year average of $443750.0 and a median of $550000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2024 — Income from Non-Controlling Interests sank 200.0% — and 2025, when it jumped 1500.0%.
- Tracing BRKR's Income from Non-Controlling Interests over 5 years: stood at $3.2 million in 2022, then sank by 128.12% to -$900000.0 in 2023, then soared by 122.22% to $200000.0 in 2024, then jumped by 1500.0% to $3.2 million in 2025, then plunged by 59.38% to $1.3 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $1.3 million (Q1 2026), $3.2 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Bruker | 9.21 Bn | 9.21 Bn | 416.00 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | -3.40 Mn |
| Mar 31, 2025 | -600,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | -500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 900,000.00 |